U.S. FDA Report (February 2026): 103 Batches of Imported Cosmetics Rejected

In January 2026, the U.S. Food and Drug Administration (FDA), under the Food, Drug, and Cosmetic Act (FD&C Act), refused entry to 151 batches of imported cosmetics from 16 countries due to regulatory non-compliance. Upon detection of violations, the FDA issued "Notices of FDA Action" to product owners or consignees, which specified the nature of the violations. Failure to demonstrate compliance or submit a corrective plan resulted in a final notice, requiring the rejected products to be exported or destroyed within 90 days.

Canada accounted for the largest share of refusals, representing over 39% of the total, followed by China, the Philippines, and South Korea.

The rejected products spanned eight categories, with makeup preparations comprising the largest portion (55.63%), followed by skin care preparations (27.81%) and personal cleanliness products (5.30%).

The leading cause of refusal was the misclassification of drugs as cosmetics, with nearly 67 cases involving products considered drugs or medical devices under U.S. regulations. Other violations included the use of non-compliant color additives and labeling deficiencies.